`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 1 of 13 Page|D# 17778
`
`
`
`
`
`
`
`EXHIBIT 11
`
`
`EXHIBIT 11
`
`
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 2 of 13 PageID# 17779
`
`
`UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF VIRGINIA
`Alexandria Division
`
`
`RAI STRATEGIC HOLDINGS, INC. and
`R.J. REYNOLDS VAPOR COMPANY,
`
`Plaintiffs and Counterclaim Defendants,
`
`
`
`
`
`
`
`v.
`
`Case No.: 1:20cv00393-LO-TCB
`
`ALTRIA CLIENT SERVICES LLC; PHILIP
`MORRIS USA, INC.; and PHILIP MORRIS
`PRODUCTS S.A.,
`
`
`
`Defendants and Counterclaim Plaintiffs.
`
`
`PLAINTIFFS RAI STRATEGIC HOLDINGS, INC. AND R.J. REYNOLDS VAPOR
`COMPANY’S TENTH SET OF REQUESTS FOR PRODUCTION TO DEFENDANT
`PHILIP MORRIS PRODUCTS S.A. (NOS. 375-394)
`
`Pursuant to Federal Rules of Civil Procedure 26 and 34, Plaintiffs RAI Strategic Holdings,
`
`Inc. (“RAI”) and R.J. Reynolds Vapor Company (“RJRV”) (collectively, “Plaintiffs”), by their
`
`undersigned attorneys, hereby request Defendant Philip Morris Products S.A. (“PMP”) respond in
`
`writing and produce the Documents and things requested below in accordance with the Definitions
`
`and Instructions contained herein, and serve such documents on Plaintiffs’ counsel, Jones Day,
`
`901 Lakeside Avenue, Cleveland, Ohio 44114, within fourteen days as required by the Court’s
`
`March 12, 2021, Order (Dkt. No. 483).
`
`DEFINITIONS
`
`1.
`
`“ACS” shall each mean and refer to Altria Client Services LLC, including without
`
`limitation all of its corporate locations, and all predecessors, predecessors-in-interest, and all past
`
`or present directors, officers, agents, representatives, employees, consultants, attorneys, entities
`
`
`
`1
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 3 of 13 PageID# 17780
`
`
`acting in joint venture, licensing agreements, or partnership relationships with ACS, and others
`
`acting on behalf of ACS.
`
`2.
`
`“Altria Accused Product” or “Altria Accused Products” shall mean any and all
`
`electric tobacco heating device systems and the associated tobacco sticks sold for use with the
`
`device systems. The tobacco heating device systems and components thereof shall include
`
`Defendants’ IQOS® System Holder and Charger (“IQOS® system”). For avoidance of doubt, the
`
`holder, charger and all compatible tobacco sticks (such as, but not limited to, IQOS® HEETS,
`
`MarlboroTM HeatSticks, MarlboroTM Fresh Menthol HeatSticks, or MarlboroTM Smooth Menthol
`
`HeatSticks) should be considered components of the respective tobacco heating device systems,
`
`and thus are included in the meaning of “Altria Accused Product” or “Altria Accused Products.”
`
`Components further shall include any smaller breakdown of parts, if applicable, to the IQOS®
`
`system and associated tobacco sticks.
`
`3.
`
`“Altria Asserted Patents” means each and any of United States Patent No.
`
`9,814,265 (“the ’265 patent”), United States Patent No. 10,555,556 (“the ’556 patent”), United
`
`States Patent No. 10,104,911 (“the ’911 patent”), United States Patent No. 6,803,545 (“the ’545
`
`patent”), and United States Patent No. 10,420,374 (“the ’374 patent”).
`
`4.
`
`“Communication” or “Communications” means every manner or method of
`
`disclosure or transfer or exchange of information, whether orally or by Document, and whether
`
`face-to-face, by telephone, mail, electronic mail, personal delivery, facsimile, or otherwise.
`
`5.
`
`“Defendants,” “Counterclaim Plaintiffs” “You,” or “Your” shall mean and refer to
`
`ACS, PM USA, and PMP.
`
`6.
`
`“Document” or “Documents” has the broadest meaning consistent with Federal
`
`Rule of Civil Procedure 34 and applicable case law, and includes electronically stored information
`
`
`
`2
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 4 of 13 PageID# 17781
`
`
`as specified in Federal Rule of Civil Procedure 34. Any draft or non-identical copy is a separate
`
`Document within the meaning of this term.
`
`7.
`
`“Person” or “Persons” shall mean any natural person, legal entity or any business
`
`entity, including but not limited to any proprietorship, firm, partnership, corporation, association,
`
`organization, or other legal entity. The acts of a Person shall include the acts of directors, officers,
`
`owners, members, employees, agents, attorneys, or other representatives acting on the Person’s
`
`behalf.
`
`8.
`
`9.
`
`“Plaintiffs” shall mean and refer to RAI and RJRV.
`
`“PM USA” shall mean and refer to Philip Morris USA, Inc., including without
`
`limitation all of its corporate locations, and all past or present directors, officers, agents,
`
`representatives, employees, consultants, attorneys, entities acting in joint venture, licensing
`
`agreements, or partnership relationships with PM USA, and others acting on behalf of PM USA.
`
`10.
`
`“PMP” shall mean and refer to Philip Morris Products S.A., including without
`
`limitation all of its corporate locations, and all past or present directors, officers, agents,
`
`representatives, employees, consultants, attorneys, entities acting in joint venture, licensing
`
`agreements, or partnership relationships with PMP, and others acting on behalf of PMP.
`
`11.
`
`“Product” or “Products” shall mean a machine, manufacture, apparatus, device,
`
`instrument, mechanism, appliance, composition of matter, assemblage of components/parts (either
`
`individually or collectively), process, or method which are designed to function together
`
`electrically, mechanically, chemically, or otherwise, to achieve a particular function or purpose,
`
`including those offered for sale, sold, or under development. “Product” or “Products” shall further
`
`include all “Altria Accused Products” or “Reynolds Accused Products” as defined in this section.
`
`
`
`3
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 5 of 13 PageID# 17782
`
`
`12.
`
`“Relate to,” “Related to,” “Relating to,” or “Concerning” shall mean in any way
`
`concerning, constituting, comprising, containing, setting forth, summarizing, reflecting, stating,
`
`describing, recording, noting, embodying, mentioning, studying, analyzing, evaluating,
`
`discussing, contemplating, or referencing a specified subject either directly or indirectly.
`
`13.
`
`“Reynolds Accused Product” or “Reynolds Accused Products” shall mean (i) the
`
`VUSE VibeTM power unit and associated flavor packs; (ii) the VUSE Alto® power unit and
`
`associated flavor packs; (iii) the VUSE Ciro® power unit and associated flavor packs, and/or (iv)
`
`VUSE Solo® power unit and associated flavor packs.
`
`14.
`
`“Reynolds Asserted Patents” means each and any of United States Patent
`
`No. 9,814,268 (“the ’268 patent”) and United States Patent No. 10,492,542 (“the ’542 patent”).1
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`“The ’268 patent” means United States Patent No. 9,814,268.
`
`“The ’542 patent” means United States Patent No. 10,492,542.
`
`“The ’265 patent” means United States Patent No. 9,814,265.
`
`“The ’556 patent” means United States Patent No. 10,555,556.
`
`“The ’911 patent” means United States Patent No. 10,104,911.
`
`“The ’545 patent” means United States Patent No. 6,803,545.
`
`“The ’374 patent” means United States Patent No. 10,420,374.
`
`
`1 Plaintiffs have additionally asserted U.S. Patent Nos. 9,839,238 (“the ’238 patent”); 9,901,123
`(“the ’123 patent”); and 9,930,915 (“the ’915 patent”). Those patents have been stayed until the
`determination of the International Trade Commission in In the Matter of Certain Tobacco Heating Articles
`and Components Thereof (Inv. No. 337-TA-1199) becomes final. Once the stay is lifted, the term “Reynolds
`Asserted Patent(s),” as used in this document, will further encompass the ’238 patent, ’123 patent, and ’915
`patent.
`
`
`
`4
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 6 of 13 PageID# 17783
`
`
`INSTRUCTIONS
`
`1.
`
`The singular form of a word should be interpreted in the plural as well. Any
`
`pronoun shall be construed to refer to the masculine, feminine, or neutral gender as in each case is
`
`most appropriate. The words “and” and “or” shall be construed conjunctively or disjunctively,
`
`whichever makes the request most inclusive. The word “including” shall be without limitation.
`
`The terms “each” and “any” shall mean any and all.
`
`2.
`
`These requests call for Documents or things that are known or available to PMP, or
`
`in PMP’s possession, custody or control, including all information known or available to PMP’s
`
`attorneys, agents, representatives, or any other Person acting or purporting to act on PMP’s behalf
`
`or under the direction or control of PMP or PMP’s attorneys, agents, representatives, or
`
`investigators.
`
`3.
`
`If PMP withholds any Document or thing, or portion thereof, in response to any of
`
`the requests set forth below on grounds of privilege or any other claim of immunity from discovery,
`
`then for each identification, Document, Communication, or portion thereof withheld, state the
`
`following:
`
`a.
`
`b.
`
`c.
`
`d.
`
`e.
`
`f.
`
`g.
`
`the type of Document (e.g., letter, memorandum, contract, etc.);
`
`its title;
`
`its date;
`
`its subject matter;
`
`the name, address, and employer at the time of preparation of the
`individual(s) who authored, drafted, or prepared it;
`
`the name, address, and employer at the time of dissemination of the
`individual(s) to whom it was directed, circulated, or copied, or who had
`access thereto; and
`
`the grounds on which the Document is being withheld (e.g., “attorney-
`client privilege,” “work product immunity,” etc.).
`
`
`
`5
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 7 of 13 PageID# 17784
`
`
`4.
`
`In the event that PMP objects to any request on the ground that it is overbroad
`
`and/or unduly burdensome for any reason, respond to that request as narrowed to the least extent
`
`necessary, in PMP’s judgment, to render it not overbroad/unduly burdensome and state specifically
`
`the extent to which PMP has narrowed that request for purposes of PMP’s response.
`
`5.
`
`In the event that PMP objects to any request on the ground that it is vague and/or
`
`ambiguous, identify the particular words, terms or phrases that are asserted to make such request
`
`vague and/or ambiguous and specify the meaning actually attributed to PMP by such words for
`
`purposes of PMP’s response thereto.
`
`6.
`
`If no Documents are responsive to a particular request, PMP is to state no
`
`responsive Documents exist.
`
`7.
`
`All Documents requested are to be produced in the same file or other organizational
`
`environment in which they are maintained. For example, a Document that is part of a file, docket,
`
`or other grouping, should be physically produced together with all other Documents from said file,
`
`docket or grouping, in the same order or manner of arrangement as the original. Alternatively, as
`
`to each Document and thing produced in response hereto, PMP shall identify the request for
`
`production and where applicable, the interrogatory number, in response to which the Document or
`
`thing is being produced. Where a Document or thing exists in hard copy and electronic format,
`
`PMP shall produce both the hard and the electronic copy.
`
`8.
`
`These requests seek all responsive Documents in their original language and, if
`
`such original language is not English, these requests also seek all English-language translations
`
`that may exist for any such documents.
`
`9.
`
`Each Document is to be produced along with all drafts, without abbreviation or
`
`redaction.
`
`
`
`6
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 8 of 13 PageID# 17785
`
`
`10.
`
`If any Document, electronically stored information, or thing has been redacted or
`
`altered in any fashion, identify the reason for the redaction or alteration, the date of the redaction
`
`or alteration and the Person performing the redaction or alteration. Make any redaction clearly
`
`visible.
`
`11.
`
`Because these discovery requests are continuing under Federal Rule of Civil
`
`Procedure 26(e), PMP remains under a duty to supplement or amend any response herein.
`
`REQUESTS FOR PRODUCTION
`
`REQUEST NO. 375:
`
`
`
`All Documents identified in PMP’s answer to Plaintiffs’ Interrogatory No. 23.
`
`REQUEST NO. 376:
`
`
`
`All Documents identified in PMP’s answer to Plaintiffs’ Interrogatory No. 24.
`
`REQUEST NO. 377:
`
`
`
`All Documents relating to the product market that PMP believes is relevant to PMP’s
`
`claims, including, but not limited to, Documents about the relevant market size, market share,
`
`relevant geographic market, and analysis of all competitors and competition.
`
`REQUEST NO. 378:
`
`
`
`All Documents relating to the relevant product market that PMP believes is relevant to
`
`PMP’s claims, including, but not limited to, Documents about the features and benefits of each of
`
`the major products in that market, consumer surveys, consumer preferences, and any expectations
`
`for changes in that market and in consumer behavior.
`
`REQUEST NO. 379:
`
`
`
`All Documents that relate to or concern any financial interest that PMP has in the sales of
`
`any products that PMP contends will be impacted if PMP’s request for a permanent injunction is
`
`
`
`7
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 9 of 13 PageID# 17786
`
`
`denied, including but not limited to Documents sufficient to show the receipt by PMP of any
`
`revenues or payments of any kind from such sales, PMP’s expected future revenues or payments
`
`associated with such sales, the contractual or other basis for PMP’s receipt of revenues or payments
`
`from such sales, and the costs and profits associated with such sales.
`
`REQUEST NO. 380:
`
`
`
`All Documents and things PMP relies on to support any contention that Plaintiffs’ VUSE
`
`products have taken away, are taking away, or are expected to take away sales of Defendants’
`
`IQOS products in the United States.
`
`REQUEST NO. 381:
`
`
`
`All Documents reflecting communications between PMP and PM USA or ACS concerning
`
`PMP’s request for a permanent injunction.
`
`REQUEST NO. 382:
`
`
`
`All Documents reflecting communications between any of the Defendants, or their agents
`
`or representatives, and JUUL Labs, Inc. or any agent or representative of JUUL Labs, Inc.
`
`concerning PMP’s request for a permanent injunction.
`
`REQUEST NO. 383:
`
`
`
`All Documents reflecting or relating to the potential impact on or benefits to JUUL Labs,
`
`Inc. if PMP’s request for a permanent injunction is granted.
`
`REQUEST NO. 384:
`
`
`
`All Documents reflecting or relating to the potential impact on or benefits to PM USA if
`
`PMP’s request for a permanent injunction is granted.
`
`
`
`8
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 10 of 13 PageID# 17787
`
`
`REQUEST NO. 385:
`
`
`
`All Documents reflecting or relating to the potential impact on or benefits to ACS if PMP’s
`
`request for a permanent injunction is granted.
`
`REQUEST NO. 386:
`
`
`
`All Documents reflecting or relating to the potential impact on or benefits to Philip Morris
`
`International Inc. if PMP’s request for a permanent injunction is granted.
`
`REQUEST NO. 387:
`
`
`
`All Documents reflecting or relating to how the public health might be impacted if
`
`Plaintiffs’ VUSE products are removed from the market due to a permanent injunction.
`
`REQUEST NO. 388:
`
`
`
`All Documents that discuss, relate to, or reflect the extent to which adult tobacco
`
`consumers switch from combustible cigarettes to Plaintiffs’ VUSE products, or the extent to which
`
`adult tobacco consumers switch from combustible cigarettes to other vaping products.
`
`REQUEST NO. 389:
`
`
`
`All Documents that relate to or concern whether the public interest will be harmed if PMP’s
`
`request for a permanent injunction is granted.
`
`REQUEST NO. 390:
`
`
`
`All Documents that refer or relate to the success of e-cigarettes in transitioning smokers
`
`away from combustible cigarettes, generally, or the success of Plaintiffs’ VUSE products, more
`
`specifically.
`
`REQUEST NO. 391:
`
`
`
`All Documents that refer or relate to the substitutability of available potentially reduced
`
`risk products or PRRPs.
`
`
`
`9
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 11 of 13 PageID# 17788
`
`
`REQUEST NO. 392:
`
`
`
`All Documents relating to the U.S. demographics that use or purchase electronic cigarettes,
`
`including but not limited to Plaintiffs’ VUSE products.
`
`REQUEST NO. 393:
`
`
`
`All Documents relating to the U.S. demographics that use or purchase heat-not-burn
`
`products, including but not limited to Plaintiffs’ Eclipse product and Defendants’ IOQS products.
`
`REQUEST NO. 394:
`
`
`
`All Documents relating to the U.S. demographics that use or purchase oral tobacco
`
`products (such as snus, chewing tobacco, pouches, and lozenges), including but not limited to
`
`either party’s oral tobacco products.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`10
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 12 of 13 PageID# 17789
`
`
`Dated: March 26, 2021
`
`Respectfully submitted,
`
`Stephanie E. Parker
`JONES DAY
`1420 Peachtree Street, N.E.
`Suite 800
`Atlanta, GA 30309
`Telephone: (404) 521-3939
`Facsimile: (404) 581-8330
`Email: separker@jonesday.com
`
`Anthony M. Insogna
`JONES DAY
`4655 Executive Drive
`Suite 1500
`San Diego, CA 92121
`Telephone: (858) 314-1200
`Facsimile: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`William E. Devitt
`JONES DAY
`77 West Wacker
`Suite 3500
`Chicago, IL 60601
`Telephone: (312) 269-4240
`Facsimile: (312) 782-8585
`Email: wdevitt@jonesday.com
`
`Sanjiv P. Laud
`JONES DAY
`90 South Seventh Street
`Suite 4950
`Minneapolis, MN 55402
`Telephone: (612) 217-8800
`Facsimile: (844) 345-3178
`Email: slaud@jonesday.com
`
`
`
`
`
`
`
`
`
`/s/ David M. Maiorana
`David M. Maiorana (VA Bar No. 42334)
`Ryan B. McCrum
`JONES DAY
`901 Lakeside Avenue
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Facsimile: (216) 579-0212
`Email: dmaiorana@jonesday.com
`Email: rbmccrum@jonesday.com
`
`John J. Normile
`JONES DAY
`250 Vesey Street
`New York, NY 10281
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: jjnormile@jonesday.com
`
`Alexis A. Smith
`JONES DAY
`555 South Flower Street
`Fiftieth Floor
`Los Angeles, CA 90071
`Telephone: (213) 243-2653
`Facsimile: (213) 243-2539
`Email: asmith@jonesday.com
`
`Charles B. Molster, III (VA Bar No. 23613)
`The Law Offices of Charles B. Molster III PLLC
`2141 Wisconsin Ave., N.W., Suite M
`Washington, DC 20007
`Telephone: (703) 346-1505
`Email: cmolster@molsterlaw.com
`
`Counsel for Plaintiffs RAI Strategic Holdings, Inc.
`and R.J. Reynolds Vapor Company
`
`
`11
`
`
`
`Case 1:20-cv-00393-LO-TCB Document 721-7 Filed 06/16/21 Page 13 of 13 PageID# 17790
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on March 26, 2021, the foregoing was served on counsel for ACS and
`
`PM USA using the following designated email address: pmiedva.lwteam@lw.com.
`
`
`
`Dated: March 26, 2021
`
`
`
`
`
`
`
`
`
`
`/s/ David M Maiorana
`David M. Maiorana (VA Bar No. 42334)
`JONES DAY
`901 Lakeside Avenue
`Cleveland, OH 44114
`Telephone: (216) 586-3939
`Facsimile: (216) 579-0212
`Email: dmaiorana@jonesday.com
`
`
`12
`
`